Martinez-Subiela Silvia, Pardo-Marín Luis, Tecles Fernando, Baneth Gad, Cerón Jose J
Interlab-UMU, Campus de Excelencia "Mare Nostrum", University of Murcia, 30100 Murcia, Spain.
School of Veterinary Medicine, Hebrew University of Jerusalem, PO Box 12, Rehovot 76100, Israel.
Res Vet Sci. 2016 Dec;109:17-20. doi: 10.1016/j.rvsc.2016.09.003. Epub 2016 Sep 9.
Monitoring of selected serum acute phase proteins like C-reactive protein (CRP) and ferritin could be useful for evaluation of the response to treatment in both naturally-occurring and experimentally-induced leishmaniosis. However studies until date have only been focused on dogs with an adequate response to the treatment and there is a lack of knowledge about the possible associations between the CRP and ferritin and the different clinicopathological conditions that can appear after treatment. Thus, the main objective of this retrospective study was to evaluate and compare the serum concentration of CRP and ferritin between three possible situations that dogs which undergo leishmaniosis treatment could have: responsive with total recovery, responsive with only clinical recovery but persistent abnormalities in biochemical analytes, and unresponsive with clinical and biochemical changes. All dogs which totally recovered after treatment showed CRP and ferritin values within reference ranges. Most of dogs classified as having only partial clinical remission had CRP and ferritin within the reference range values despite the presence of other biochemical abnormalities such as hyperglobulinemia, hyperproteinemia, or proteinuria. On the other hand, most of dogs in the unresponsive group had increased CRP and ferritin. Although the study has limitations due to the variability in the protocols and time periods of treatments, it can be concluded that CRP and ferritin concentrations within the reference ranges are usually associated with the absence of clinical signs and adequate response to treatment and increased CRP and/or ferritin values could reflect a lack of appropriate response to treatment.
监测某些血清急性期蛋白,如C反应蛋白(CRP)和铁蛋白,可能有助于评估自然发生和实验诱导的利什曼病的治疗反应。然而,迄今为止的研究仅集中在对治疗有充分反应的犬只上,对于CRP和铁蛋白与治疗后可能出现的不同临床病理状况之间的潜在关联缺乏了解。因此,这项回顾性研究的主要目的是评估和比较接受利什曼病治疗的犬只可能出现的三种情况之间的血清CRP和铁蛋白浓度:完全康复的反应性、仅临床康复但生化分析物持续异常的反应性以及临床和生化均无变化的无反应性。所有治疗后完全康复的犬只的CRP和铁蛋白值均在参考范围内。大多数被归类为仅部分临床缓解的犬只,尽管存在其他生化异常,如高球蛋白血症、高蛋白血症或蛋白尿,但其CRP和铁蛋白仍在参考范围内。另一方面,无反应组的大多数犬只的CRP和铁蛋白升高。尽管由于治疗方案和时间段的变异性,该研究存在局限性,但可以得出结论,参考范围内的CRP和铁蛋白浓度通常与无临床症状和对治疗的充分反应相关,而CRP和/或铁蛋白值升高可能反映对治疗缺乏适当反应。